Lizhu Lin

888 total citations
14 papers, 158 citations indexed

About

Lizhu Lin is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lizhu Lin has authored 14 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Lizhu Lin's work include Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Lizhu Lin is often cited by papers focused on Ferroptosis and cancer prognosis (4 papers), RNA modifications and cancer (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Lizhu Lin collaborates with scholars based in China and United States. Lizhu Lin's co-authors include Zeyun Li, Lingling Sun, Ruiting Lin, Tong Lin, Guoming Chen, Zhiqiang Chen, Xiaozhong Liao, Xiangjun Qi, Wei Liu and Jiamin Luo and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and Frontiers in Pharmacology.

In The Last Decade

Lizhu Lin

11 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lizhu Lin China 6 69 46 26 23 19 14 158
Shah Zeb Khan Italy 6 89 1.3× 55 1.2× 36 1.4× 10 0.4× 4 0.2× 15 220
Zhenyu Zou China 10 58 0.8× 145 3.2× 38 1.5× 16 0.7× 7 0.4× 25 301
Fanchao Feng China 10 83 1.2× 35 0.8× 157 6.0× 42 1.8× 4 0.2× 33 317
Anup Kumar Bhowmick India 7 67 1.0× 43 0.9× 29 1.1× 10 0.4× 17 0.9× 17 173
Chengcheng Fan China 10 62 0.9× 84 1.8× 122 4.7× 3 0.1× 10 0.5× 35 326
Di Han China 10 98 1.4× 63 1.4× 118 4.5× 44 1.9× 2 0.1× 32 328
Weiwen Li China 10 110 1.6× 44 1.0× 51 2.0× 7 0.3× 3 0.2× 42 270
Zhang Li China 7 142 2.1× 58 1.3× 65 2.5× 31 1.3× 2 0.1× 52 317
Linda Backman Sweden 6 109 1.6× 20 0.4× 32 1.2× 26 1.1× 7 0.4× 6 331
Liyuan Hao China 11 170 2.5× 67 1.5× 45 1.7× 17 0.7× 2 0.1× 41 327

Countries citing papers authored by Lizhu Lin

Since Specialization
Citations

This map shows the geographic impact of Lizhu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lizhu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lizhu Lin more than expected).

Fields of papers citing papers by Lizhu Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lizhu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lizhu Lin. The network helps show where Lizhu Lin may publish in the future.

Co-authorship network of co-authors of Lizhu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Lizhu Lin. A scholar is included among the top collaborators of Lizhu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lizhu Lin. Lizhu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Sun, Lingling, et al.. (2025). Anti-lung cancer therapy using nano-assembly particles of traditional Chinese Medicine formula. Materials Today Bio. 35. 102502–102502.
2.
Zhang, Zikang, et al.. (2025). Lactobacillus gasseri LGV03-derived indole-3-lactic acid ameliorates immune response by activating aryl hydrocarbon receptor. Microbial Cell Factories. 24(1). 34–34. 2 indexed citations
3.
4.
Gu, Shanzhi, Tie Zhou, Lizhu Lin, et al.. (2023). [A phase I study of subcutaneous envafolimab (KN035) monotherapy in Chinese patients with advanced solid tumors].. PubMed. 45(10). 898–903. 3 indexed citations
5.
Chen, Wen‐Ming, et al.. (2022). Comprehensive analysis of clinical prognosis and CLIC1 immune invasion in lung adenocarcinoma. Medicine. 101(39). e30760–e30760. 3 indexed citations
6.
Luo, Jiamin, et al.. (2022). Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation. Drugs of today. 58(4). 175–185. 14 indexed citations
7.
Feng, Jingyu, et al.. (2022). Upregulated expression of NOP2 predicts worse prognosis of gastric adenocarcinoma by promoting tumor growth. Saudi Journal of Gastroenterology. 28(5). 369–377. 8 indexed citations
8.
Yang, Hongxing, Qiuyan Guo, Jianbin Wu, et al.. (2022). Deciphering the Effects and Mechanisms of Yi-Fei-San-Jie-pill on Non-Small Cell Lung Cancer With Integrating Network Target Analysis and Experimental Validation. Frontiers in Pharmacology. 13. 851554–851554. 10 indexed citations
9.
10.
Xiao, Zhiwei, Zhiqiang Chen, Rui Han, et al.. (2021). Comprehensive TCM treatments combined with chemotherapy for advanced non-small cell lung cancer. Medicine. 100(18). e25690–e25690. 18 indexed citations
11.
Chen, Zhiqiang, Tong Lin, Xiaozhong Liao, et al.. (2021). Network pharmacology based research into the effect and mechanism of Yinchenhao Decoction against Cholangiocarcinoma. Chinese Medicine. 16(1). 13–13. 69 indexed citations
12.
Li, Jiayin, Jingxu Zhou, Jing Zhang, et al.. (2021). DNA repair genes are associated with tumor tissue differentiation and immune environment in lung adenocarcinoma: a bioinformatics analysis based on big data. Journal of Thoracic Disease. 13(7). 4464–4475. 3 indexed citations
13.
Fang, Chongkai, Liting Yang, Ruilin Huang, et al.. (2019). Treatment of syncope in tongue cancer with palliative chemotherapy in the intensive care unit. Medicine. 98(35). e16998–e16998. 4 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shah Zeb Khan Breakdown of academic impact, for papers by Zhenyu Zou Breakdown of academic impact, for papers by Fanchao Feng Breakdown of academic impact, for papers by Anup Kumar Bhowmick Breakdown of academic impact, for papers by Chengcheng Fan Breakdown of academic impact, for papers by Di Han Breakdown of academic impact, for papers by Weiwen Li Breakdown of academic impact, for papers by Zhang Li Breakdown of academic impact, for papers by Linda Backman Breakdown of academic impact, for papers by Liyuan Hao
Rankless by CCL
2026